Madhav Thambisetty
@MadhavThambiset
Neurologist. Neuroscientist. Discovering cures for Alzheimer's disease. Tweets are my personal opinions.
ID:1891603776
https://www.linkedin.com/in/madhav-thambisetty-599a9776 21-09-2013 22:10:07
3,5K Tweets
1,1K Followers
983 Following
Misleading to claim #donanemab or any amyloid lowering Rx will allow an #Alzheimer ’s patient to continue to drive independently. Inserting the claim immediately outside a respected KOL’s quote also risks wrongly attributing this to them. Not a good look Robert Howard Ash Paul
Is amyloid=Alzheimers? YES: Alzheimer's Association
Does lowering brain amyloid predict benefit? YES: U.S. FDA
Is lowering brain amyloid safe & effective? YES: drug makers
Should we cover amyloid abs? YES: CMS
Should we prescribe them? YES: MDs #Consensus #no -debate Alberto J Espay
Only 1 in 4 respondents to a recent McKnight Brain survey have talked to their doctor about brain health. Talking to your doctor is a great way to be proactive about maintaining your brain health. Learn more & get tips to start the conversation here: McKnightBrain.org/BrainWorks.
Fewer Than 1/2 of Accelerated Approval Rx Showed Clinical Benefit in Confirmatory Trials After 5 Years tinyurl.com/ydfznwx3
Dave Weisman Oliver Barnes Ash Paul Robert Howard A sobering and timely analysis suggesting that cancer-envy in dementia drug approvals may be misplaced
A breathtaking story indeed. James Temperton 🙏 thanks for writing it. Inspiring, sobering, uplifting and sad in equal measure. Jason Mast did you see this?
We're excited to be kicking off Cognitive Aging Summit IV in partnership with Foundation for the National Institutes of Health & The National Institute on Aging (NIA). Scientific presentations on the social, biologic & genetic factors that drive healthy aging are underway. If you aren't here, join us virtually at: fnih.org/our-programs/c….
The fourth Cognitive Aging Summit is underway!
It’s not too late to join us via livestream to learn about the individual factors that affect brain health as we age: lnkd.in/eJbBhZhV
McKnight Brain The National Institute on Aging (NIA)
#CASIV #aging #healthyaging #fnih
A friendly, respectful & collegial debate on the pros & cons of amyloid-targeting antibodies at the #ASENT meeting in Bethesda ASENT.org with Dave Weisman Alberto J Espay & John Dickson from MGH. Thanks for participating!
Safe to say this is the most head spinning, vertigo-inducing day for neurodegenerative diseases that I can recall Robert Howard Ash Paul Alberto J Espay Matthew Schrag Tharick Pascoal
Effects of unblinding may explain a significant share of the observed treatment effects for all amyloid-targeting Rx Sarah Ackley, PhD Robert Howard Kathy Liu Lon S. Schneider, MD Maria Glymour Nicolas Villain Matthew Schrag